Grow Opportunity

Markets News Marketing Retail
Avicanna launching RHO Phyto CBD/THC products with the addition of CBG in Canada

April 28, 2022  By Grow Opportunity staff

Toronto-based biopharmaceutical company Avicanna Inc. is expanding its RHO Phyto formulary in Canada with Cannabigerol (CBG) formulations into medical and adult-use channels across the country.

The formulations will be made available across various medical cannabis channels, including Medical Cannabis by Shoppers and adult-use channels beginning with its two listings on the Ontario Cannabis Store in the third quarter of 2022.

CBG is a rare and non-psychoactive cannabinoid which acts as the precursor to other more commonly known cannabinoids including CBD and THC, CBG, interacts with several receptors throughout the skin and body that are known to be targets for inflammation, infection, pain, as well as neurological and mood related disorders.

Avicanna’s initial CBG formulations will include:

  • RHO Phyto Rapid Act THC:CBG Spray: A combination of THC and CBG in a lemon-mint flavoured spray that utilizes Avicanna’s sublingual delivery technology for fast onset.
  • RHO Phyto Micro Drop THC:CBG:CBD Oil: A combination of THC, CBG and CBD in a blood orange flavored oil which utilizes Avicanna’s inverted emulsion technology to provide enhanced absorption and shelf-life stability.
  • RHO Phyto CBG Transdermal Relief Gel: A combination of CBG and CBD in a fast absorbing, water-based gel. The gel employs Avicanna’s deep tissue technology and combines cannabinoids with synergistic natural ingredients and terpenes including menthol and beta-caryophyllene.

Print this page


Stories continue below